Abbott glucose meter patent suit
This article was originally published in The Gray Sheet
Executive Summary
San Francisco federal jury rules Aug. 8 that Abbott patent '890 related to blood glucose monitors and test strips is invalid. Abbott had asserted in 2004 that Becton Dickinson and Nova Biomedical, which manufactured certain BD products including the BD Logic monitor, infringed four of its patents. The latest ruling relieves BD/Nova from the last of the four claims. A judge ruled in April that two of the other patents had not been infringed and one was invalid. Abbott had sought $42 million in damages. BD exited the glucose monitoring market in 2006 (1"The Gray Sheet" Oct. 2, 2006, p. 13)